Lifeboat Foundation

Sound familiar? The team basically built molecular devices that “die” without “food.” Thanks to the laws of thermodynamics (hey ya, Newton!), that energy eventually dissipates, and the shapes automatically begin to break down, completing an artificial “circle of life.”

The new study took the system one step further: rather than just mimicking synthesis, they completed the circle by coupling the building process with dissipative assembly.

Continue reading “New Lifelike Biomaterial Self-Reproduces and Has a Metabolism” »

Scientists have discovered a new species of crab that swam the seas 95 million years ago — and behold, it could be the next Pixar character.

The small, pocket-size crab, named Callichimaera perplexa, was different than its modern cousins.

This crab sported a tiny lobster-esque shell, with legs flattened like oars, and huge Pound Puppies-style peepers that protruded from its head — a trait that indicates the creature used its eyes actively for whatever it did, researchers said.

Continue reading “This 90-Million-Year-Old Crab Chimera Is a Beautiful Mess of an Animal” »

In a recent study in mice, researchers found a way to deliver specific drugs to parts of the body that are exceptionally difficult to access. Their Y-shaped block catiomer (YBC) binds with certain therapeutic materials forming a package 18 nanometers wide. The package is less than one-fifth the size of those produced in previous studies, so it can pass through much smaller gaps. This allows YBCs to slip through tight barriers in cancers of the brain or pancreas.

The fight against cancer is fought on many fronts. One promising field is gene therapy, which targets genetic causes of diseases to reduce their effect. The idea is to inject a nucleic acid-based drug into the bloodstream—typically small interfering RNA (siRNA)—which binds to a specific problem-causing gene and deactivates it. However, siRNA is very fragile and needs to be protected within a nanoparticle or it breaks down before reaching its target.

“siRNA can switch off specific gene expressions that may cause harm. They are the next generation of biopharmaceuticals that could treat various intractable diseases, including cancer,” explained Associate Professor Kanjiro Miyata of the University of Tokyo, who jointly supervised the study. “However, siRNA is easily eliminated from the body by enzymatic degradation or excretion. Clearly a new delivery method was called for.”

Continue reading “New nanomedicine slips through the cracks” »

Tesla has begun delivering the $35,000, base-priced version of its Model 3 sedan, three customers have told Business Insider. Electrek first reported on April 15 that Tesla had started delivering the $35,000 Model 3, known as the standard-range trim.

The beginning of standard-range Model 3 deliveries is a landmark for Tesla, but the electric-car maker has been unusually quiet about it. While Tesla posted on its website and social media accounts when it began allowing customers to order the standard-range trim in February, the company has only made reference to the beginning of deliveries near the bottom of an April 11 blog post about an update to its product offerings.

How unaware things became aware.

Support Kurzgesagt – In a Nutshell on Patreon so they can make more videos (and get cool stuff in return): https://www.patreon.com/Kurzgesagt?ty=h

Continue reading “The Origin of Consciousness” »

After 20 years of dedicated research, scientists have cracked the chemical code of an incredibly complex ‘anti-tumor antibiotic’ known to be highly effective against cancer cells as well as drug-resistant bacteria, and have reproduced it synthetically in the lab for the first time.

This major breakthrough and world-first could hail a new era in the design and production of new antibiotics and anticancer agents.

The ‘super substance’ — kedarcidin — was discovered in its natural form by a pharmaceutical company when they extracted it from a soil sample in India almost 30-years-ago. Soil is the natural source of all antibiotics developed since the 1940s but in order for them to be developed as potential drug treatments they must be produced via chemical synthesis.

Continue reading “Scientists crack chemical code of incredibly complex ‘anti-tumor antibiotic’” »

Now, a pair of research papers published the week of April 22 from the University of Washington — one in the Journal of Neuroscience, the other in the Proceedings of the National Academy of Sciences — use functional MRI to identify two differences in the brains of blind individuals that might be responsible for their abilities to make better use of auditory information.

“There’s this idea that blind people are good at auditory tasks, because they have to make their way in the world without visual information. We wanted to explore how this happens in the brain,” said Ione Fine, a UW professor of psychology and the senior author on both studies.

Instead of simply looking to see which parts of the brain were most active while listening, both studies examined the sensitivity of the brain to subtle differences in auditory frequency.

Continue reading “Brains of blind people adapt to sharpen sense of hearing, study shows” »

We’ve seen the destruction a powerful tidal wave can cause above water. But what happens underwater?

The ‘Vessel’ says it owns every photo taken on the grounds.